ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Crystal Field Engineering of Bioinspired Dual-Metal Single-Atom Catalysts Via Spin-State Modulation for Efficient Oxygen Electroreduction.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The oxygen reduction reaction (ORR) is central to next-generation energy technologies, but its practical implementation is constrained by inherently sluggish kinetics. Herein, we propose a bioinspired strategy that synergistically integrate atomic-scale crystal field engineering and hierarchical porosity design, effectively tackling the intrinsic activity and mass transport limitations of ORR. This strategy is realized in a Fe/Co dual-metallic single-atom sites anchored on hierarchical meso/microporous N-doped carbon matrices (MPNC-FeCo-x). The optimized MPNC-FeCo-4 exhibits remarkable ORR performance with a half-wave potential of 0.923 V and a turnover frequency of 2.01 e
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.